Tirzepatide × Mile High Compounds - Lab Test, March 2026
Kovera Labs publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
Test results
About this test
This independent RP-HPLC lab test confirms Tirzepatide 60mg from Mile High Compounds at 99.929% purity. The analysis was conducted by Kovera Labs on March 18, 2026 (Report #KVR-2026-195519). Identity was confirmed via LC-MS, and microbial sterility screening returned no growth.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for metabolic regulation, weight management, and glycemic control. A four-vial batch conformity test was performed, with individual vial purities ranging from 99.898% to 99.966%. Heavy metals screening for lead, cadmium, arsenic, and mercury all returned negative results.
The full certificate of analysis is available using Report #KVR-2026-195519 and access code VGMJVX.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion
No comments yet. Sign in to be the first to discuss this test.